Compare
AARD · 1 ticker
Price
100 is the close on the leftSnapshot
best blue · worst red
AARD
Aardvark Therapeutics Inc
1.52
-0.07 (-4.40%)
Valuation
| Market Cap | $33.26M |
|---|---|
| Enterprise Value | -39.93M |
| Income | -69.89M |
| Sales | 0.00M |
| Book / share | 3.42 |
| Cash / share | 3.38 |
| Dividend Gr. 3/5Y | - - |
| Employees | 40 |
| IPO | Feb 13, 2025 |
Ratios
| Price / book | 0.44 |
|---|---|
| Price / cash | 0.45 |
| Quick Ratio | 12.63 |
| Current Ratio | 12.63 |
| Debt / equity | 0.01 |
| Long-term debt / equity | 0.00 |
| Options and short | Yes / No |
Earnings
| Earnings / share | -3.21 |
|---|---|
| Earnings next year | -2.36 |
| Earnings next quarter | -0.72 |
| Earnings this year | -5.15% |
| Earnings growth, 5 years | 8.96% |
| Past earnings growth | -60.85% - |
| Past sales growth | - - |
| Earnings vs last year | -89.45% |
| Earnings vs last quarter | 0.56% |
| Earnings | Nov 12 · 1 day ago |
| Surprise | 24.52% - |
Ownership
| Insiders own | 41.42% |
|---|---|
| Insider trades | -0.84% |
| Institutions own | 25.05% |
| Institution trades | -6.84% |
| Return on assets | -61.06% |
| Return on equity | -66.02% |
| Return on capital | -93.09% |
| 20-day average | -23.35% |
| 50-day average | -60.49% |
| 200-day average | -73.36% |
Technical
| Shares out | 21.88M |
|---|---|
| Shares floating | 12.82M |
| Short / float | 8.10% |
| Short ratio | 1.69 |
| Short interest | 1.04M |
| 52-week high | 16.60 -90.8% |
| 52-week low | 0.93 +63.4% |
| Volatility | 14.70% 20.50% |
| Average range | 0.36 |
| Strength index | 33.74 |
| Market sensitivity | 4.30 |
| Relative volume | 0.00 |
| Avg Volume | 614.02K |
| Volume | 0 |
Performance
| Perf Week | 36.94% |
|---|---|
| Perf Month | -60.82% |
| Perf Quarter | -76.76% |
| Perf Half Y | -77.41% |
| Perf YTD | -88.42% |
| Perf Year | -85.83% |
| Recommendation | 2.55 |
| Target Price | 4.57 |
| Prev Close | 1.52 |
| Price | 1.52 |
| Change % | 0.00% |
Compare
| AARD | |
|---|---|
| Price | 1.52 |
| Change | -0.07 (-4.40%) |
Compare · Valuation
| AARD | |
|---|---|
| Market Cap | $33.26M |
| Enterprise Value | -39.93M |
| Income | -69.89M |
| Sales | 0.00M |
| Book / share | 3.42 |
| Cash / share | 3.38 |
| Dividend Gr. 3/5Y | - - |
| Employees | 40 |
| IPO | Feb 13, 2025 |
Compare · Ratios
| AARD | |
|---|---|
| Price / book | 0.44 |
| Price / cash | 0.45 |
| Quick Ratio | 12.63 |
| Current Ratio | 12.63 |
| Debt / equity | 0.01 |
| Long-term debt / equity | 0.00 |
| Options and short | Yes / No |
Compare · Earnings
| AARD | |
|---|---|
| Earnings / share | -3.21 |
| Earnings next year | -2.36 |
| Earnings next quarter | -0.72 |
| Earnings this year | -5.15% |
| Earnings growth, 5 years | 8.96% |
| Past earnings growth | -60.85% - |
| Past sales growth | - - |
| Earnings vs last year | -89.45% |
| Earnings vs last quarter | 0.56% |
| Earnings | Nov 12 · 1 day ago |
| Surprise | 24.52% - |
Compare · Ownership
| AARD | |
|---|---|
| Insiders own | 41.42% |
| Insider trades | -0.84% |
| Institutions own | 25.05% |
| Institution trades | -6.84% |
| Return on assets | -61.06% |
| Return on equity | -66.02% |
| Return on capital | -93.09% |
| 20-day average | -23.35% |
| 50-day average | -60.49% |
| 200-day average | -73.36% |
Compare · Technical
| AARD | |
|---|---|
| Shares out | 21.88M |
| Shares floating | 12.82M |
| Short / float | 8.10% |
| Short ratio | 1.69 |
| Short interest | 1.04M |
| 52-week high | 16.60 -90.8% |
| 52-week low | 0.93 +63.4% |
| Volatility | 14.70% 20.50% |
| Average range | 0.36 |
| Strength index | 33.74 |
| Market sensitivity | 4.30 |
| Relative volume | 0.00 |
| Avg Volume | 614.02K |
| Volume | 0 |
Compare · Performance
| AARD | |
|---|---|
| Perf Week | 36.94% |
| Perf Month | -60.82% |
| Perf Quarter | -76.76% |
| Perf Half Y | -77.41% |
| Perf YTD | -88.42% |
| Perf Year | -85.83% |
| Recommendation | 2.55 |
| Target Price | 4.57 |
| Prev Close | 1.52 |
| Price | 1.52 |
| Change % | 0.00% |